ArticleBirth defects research. Part A, Clinical and molecular teratology2010
Women's perspectives on counseling about risks for medication-induced birth defects.
Article in Birth defects research. Part A, Clinical and molecular teratology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02293213 (Utilizing Electronic Medical Record Referrals for Teratogen and Contraceptive Counseling for Women Taking Category D or X Medications), which is not on this map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Utilizing Electronic Medical Record Referrals for Teratogen and Contraceptive Counseling for Women Taking Category D or X Medications: A Randomized Controlled Trial
Who cites it
21 citing papers in PubMed, 36 citations in OpenAlex.
- Clinical decision support to promote safe prescribing to women of reproductive age: a cluster-randomized trial.Journal of general internal medicine · 2012Trial
- Promoting safe prescribing in primary care with a contraceptive vital sign: a cluster-randomized controlled trial.Annals of family medicineTrial
- Special Considerations for Women of Reproductive Age on Anticoagulation.Journal of general internal medicine · 2022Review
- True Choice in Reproductive Care: Using Cultural Humility and Explanatory Models to Support Reproductive Justice in Primary Care.Journal of general internal medicine · 2021Article
- "I know my body better than you:" patient focus groups to inform a decision aid on oral corticosteroid use during pregnancy.Pharmacoepidemiology and drug safety · 2021Article
- A Qualitative Study of Pregnant Women's Perspectives on Antibiotic Use for Mom and Child: Implications for Developing Tailored Health Education Interventions.Antibiotics (Basel, Switzerland) · 2020Article
- Perceptions of the Value of Clinical Pharmacy Medication Review for Women During Early Pregnancy.Journal of managed care & specialty pharmacy · 2020Article
- Treatment and Management of Depression Symptoms in Pregnant Veterans: Varying Experiences of Mental Health Care in the Prenatal Period.The Psychiatric quarterly · 2020Article
- Pharmacists and Contraception in the Inpatient Setting.Pharmacy (Basel, Switzerland) · 2020Article
- Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects.Journal of the International AIDS Society · 2019Article
- Making Decisions About Medication Use During Pregnancy: Implications for Communication Strategies.Maternal and child health journal · 2018Article
- Improving Safe Use of Medications During Pregnancy: The Roles of Patients, Physicians, and Pharmacists.Qualitative health research · 2017Article
- Why women do not ask for information on preconception health? A qualitative study.BMC pregnancy and childbirth · 2017Article
- Using the electronic medical record to assess contraception usage among women taking category D or X medications.Birth defects research. Part A, Clinical and molecular teratology · 2015Article
- Using the electronic medical record to refer women taking category D or X medications for teratogen and contraceptive counseling.Birth defects research. Part A, Clinical and molecular teratology · 2015Article
- Pilot study of reproductive health counseling in a pediatric rheumatology clinic.Arthritis care & research · 2014Article
- Counseling about medication-induced birth defects with clinical decision support in primary care.Journal of women's health (2002) · 2013Article
- Counseling of female veterans about risks of medication-induced birth defects.Journal of general internal medicine · 2013Article
- Teratogenic risk perception and confidence in use of medicines in pairs of pregnant women and general practitioners based on patient information leaflets.Drug safety · 2013Article
- Impact of physician counseling and perception of teratogenic risks: a survey of 96 nonpregnant women with anxiety.The primary care companion for CNS disorders · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
Abstract
purposeThis qualitative study explored women's experiences with counseling about medication-induced birth defects, as well as how and when they would like to receive information on medication-induced birth defects from their health care providers (HCPs).
methodsWe conducted four focus groups with 36 women of reproductive age (18-45 years old) in Pittsburgh, Pennsylvania. Twenty-one women were using medications to treat a chronic health condition, and two were pregnant. Content analysis was performed by three independent coders using a grounded theory approach. Discrepancies were resolved by consensus.
resultsWomen reported depending on their HCPs for information about the risks of teratogenic effects of medications on a pregnancy, but felt the information they had been provided was not always comprehensive. Women want HCPs to initiate discussions about potentially teratogenic medications at the time the medications are prescribed, regardless of whether the woman is sexually active or planning a pregnancy. Women want clear information about all potential outcomes for a fetus. Factors women reported as being critical to effective teratogenic risk counseling included privacy, sufficient time to discuss the topic, and a trusting relationship with their HCP.
conclusionsWomen of reproductive age think that providing information about the possible teratogenic effects of medications could be improved by routine discussions of teratogenic risks at the time medications are prescribed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.